{"entity":{"type":"insider","cik":"0001502240","url":"/insider/0001502240","json_url":"/insider/0001502240.json","name":"OrbiMed Capital GP IV LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":195,"n_filings":55,"first":"2010-10-04","last":"2024-07-02","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Capital GP IV LLC","source":"filing","n_filings":55,"first_seen":"2010-10-04","last_seen":"2024-07-02"}],"transactions":[{"id":2339422,"accession":"0000947871-24-000583","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-24-000583","line_url":"/filing/0000947871-24-000583#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36600.0,"shares_display":"36,600","price_per_share":4.54,"price_display":"4.54","price_state":"stated","total_value":166164.0,"total_display":"166,164.00","total_whole":"166,164","shares_owned_after":2407242.0,"shares_owned_after_display":"2,407,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-02","filed_date":"2024-07-02","scope":"insider"},{"id":2339418,"accession":"0000947871-24-000583","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-24-000583","line_url":"/filing/0000947871-24-000583#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13700.0,"shares_display":"13,700","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":64116.0,"total_display":"64,116.00","total_whole":"64,116","shares_owned_after":2443842.0,"shares_owned_after_display":"2,443,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-02","scope":"insider"},{"id":2339413,"accession":"0000947871-24-000583","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000583","line_url":"/filing/0000947871-24-000583#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":378000.0,"shares_display":"378,000","price_per_share":4.74,"price_display":"4.74","price_state":"stated","total_value":1791720.0,"total_display":"1,791,720.00","total_whole":"1,791,720","shares_owned_after":2457542.0,"shares_owned_after_display":"2,457,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-28","filed_date":"2024-07-02","scope":"insider"},{"id":8670465,"accession":"0000947871-23-000484","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-23-000484","line_url":"/filing/0000947871-23-000484#line-3","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27700.0,"shares_display":"27,700","price_per_share":9.41,"price_display":"9.41","price_state":"stated","total_value":260657.0,"total_display":"260,657.00","total_whole":"260,657","shares_owned_after":2835542.0,"shares_owned_after_display":"2,835,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-21","filed_date":"2023-04-21","scope":"insider"},{"id":8670462,"accession":"0000947871-23-000484","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-23-000484","line_url":"/filing/0000947871-23-000484#line-2","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28300.0,"shares_display":"28,300","price_per_share":9.43,"price_display":"9.43","price_state":"stated","total_value":266869.0,"total_display":"266,869.00","total_whole":"266,869","shares_owned_after":2863242.0,"shares_owned_after_display":"2,863,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-21","scope":"insider"},{"id":8670458,"accession":"0000947871-23-000484","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-23-000484","line_url":"/filing/0000947871-23-000484#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136000.0,"shares_display":"136,000","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":1264800.0,"total_display":"1,264,800.00","total_whole":"1,264,800","shares_owned_after":2891542.0,"shares_owned_after_display":"2,891,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-04-19","filed_date":"2023-04-21","scope":"insider"},{"id":4828548,"accession":"0000947871-21-000788","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-21-000788","line_url":"/filing/0000947871-21-000788","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Acutus Medical, Inc.","issuer_ticker":"AFIB","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC; Orbimed ROF II LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1071428.0,"shares_display":"1,071,428","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":14999992.0,"total_display":"14,999,992.00","total_whole":"14,999,992","shares_owned_after":4872025.0,"shares_owned_after_display":"4,872,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-21","scope":"insider","n_lines":2},{"id":3035379,"accession":"0000950103-20-015724","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950103-20-015724","line_url":"/filing/0000950103-20-015724","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Acutus Medical, Inc.","issuer_ticker":"AFIB","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"Orbimed ROF II LLC; OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"Orbimed ROF II LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":415000.0,"shares_display":"415,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":7470000.0,"total_display":"7,470,000.00","total_whole":"7,470,000","shares_owned_after":373500.0,"shares_owned_after_display":"373,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-10","filed_date":"2020-08-12","scope":"insider","n_lines":2},{"id":2170817,"accession":"0000947871-20-000388","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-20-000388","line_url":"/filing/0000947871-20-000388","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62183.0,"shares_display":"62,183","price_per_share":23.53,"price_display":"23.53","price_state":"stated","total_value":1463165.99,"total_display":"1,463,165.99","total_whole":"1,463,166","shares_owned_after":5955674.0,"shares_owned_after_display":"5,955,674","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-16","filed_date":"2020-04-16","scope":"insider","n_lines":2},{"id":2170812,"accession":"0000947871-20-000388","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000388","line_url":"/filing/0000947871-20-000388","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23231.0,"shares_display":"23,231","price_per_share":23.52,"price_display":"23.52","price_state":"stated","total_value":546393.12,"total_display":"546,393.12","total_whole":"546,393","shares_owned_after":6002771.0,"shares_owned_after_display":"6,002,771","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-14","filed_date":"2020-04-16","scope":"insider","n_lines":2},{"id":2734520,"accession":"0000947871-20-000371","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-20-000371","line_url":"/filing/0000947871-20-000371","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":288101.0,"shares_display":"288,101","price_per_share":23.79,"price_display":"23.79","price_state":"stated","total_value":6853922.79,"total_display":"6,853,922.79","total_whole":"6,853,923","shares_owned_after":6020366.0,"shares_owned_after_display":"6,020,366","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-09","filed_date":"2020-04-09","scope":"insider","n_lines":2},{"id":2734509,"accession":"0000947871-20-000371","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-20-000371","line_url":"/filing/0000947871-20-000371","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82614.0,"shares_display":"82,614","price_per_share":23.65,"price_display":"23.65","price_state":"stated","total_value":1953821.1,"total_display":"1,953,821.10","total_whole":"1,953,821","shares_owned_after":6238574.0,"shares_owned_after_display":"6,238,574","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-09","scope":"insider","n_lines":2},{"id":2734500,"accession":"0000947871-20-000371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000371","line_url":"/filing/0000947871-20-000371","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9170.0,"shares_display":"9,170","price_per_share":23.1,"price_display":"23.10","price_state":"stated","total_value":211827.0,"total_display":"211,827.00","total_whole":"211,827","shares_owned_after":6301147.0,"shares_owned_after_display":"6,301,147","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-07","filed_date":"2020-04-09","scope":"insider","n_lines":2},{"id":2170785,"accession":"0000947871-20-000317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000317","line_url":"/filing/0000947871-20-000317","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":24.5,"price_display":"24.50","price_state":"stated","total_value":6125000.0,"total_display":"6,125,000.00","total_whole":"6,125,000","shares_owned_after":6308093.0,"shares_owned_after_display":"6,308,093","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-31","filed_date":"2020-04-02","scope":"insider","n_lines":2},{"id":3281598,"accession":"0000947871-20-000288","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-20-000288","line_url":"/filing/0000947871-20-000288","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56411.0,"shares_display":"56,411","price_per_share":24.66,"price_display":"24.66","price_state":"stated","total_value":1391095.26,"total_display":"1,391,095.26","total_whole":"1,391,095","shares_owned_after":6497448.0,"shares_owned_after_display":"6,497,448","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-25","filed_date":"2020-03-25","scope":"insider","n_lines":2},{"id":3281591,"accession":"0000947871-20-000288","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-20-000288","line_url":"/filing/0000947871-20-000288","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67644.0,"shares_display":"67,644","price_per_share":24.45,"price_display":"24.45","price_state":"stated","total_value":1653895.8,"total_display":"1,653,895.80","total_whole":"1,653,896","shares_owned_after":6540175.0,"shares_owned_after_display":"6,540,175","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-24","filed_date":"2020-03-25","scope":"insider","n_lines":2},{"id":3281582,"accession":"0000947871-20-000288","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-20-000288","line_url":"/filing/0000947871-20-000288","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14598.0,"shares_display":"14,598","price_per_share":26.05,"price_display":"26.05","price_state":"stated","total_value":380277.9,"total_display":"380,277.90","total_whole":"380,278","shares_owned_after":6591410.0,"shares_owned_after_display":"6,591,410","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-23","filed_date":"2020-03-25","scope":"insider","n_lines":2},{"id":2792799,"accession":"0000947871-20-000183","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-20-000183","line_url":"/filing/0000947871-20-000183","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1874203.0,"shares_display":"1,874,203","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":48729278.0,"total_display":"48,729,278.00","total_whole":"48,729,278","shares_owned_after":6602467.0,"shares_owned_after_display":"6,602,467","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider","n_lines":3},{"id":2686398,"accession":"0000947871-20-000023","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-20-000023","line_url":"/filing/0000947871-20-000023","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED ADVISORS LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":379997.0,"shares_display":"379,997","price_per_share":19.5,"price_display":"19.50","price_state":"stated","total_value":7409941.5,"total_display":"7,409,941.50","total_whole":"7,409,942","shares_owned_after":7992776.0,"shares_owned_after_display":"7,992,776","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-09","filed_date":"2020-01-13","scope":"insider","n_lines":3},{"id":7859347,"accession":"0000947871-19-000992","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000947871-19-000992","line_url":"/filing/0000947871-19-000992","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10800.0,"shares_display":"10,800","price_per_share":18.6,"price_display":"18.60","price_state":"stated","total_value":200880.0,"total_display":"200,880.00","total_whole":"200,880","shares_owned_after":8279563.0,"shares_owned_after_display":"8,279,563","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2019-12-26","scope":"insider","n_lines":3},{"id":7859338,"accession":"0000947871-19-000992","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000947871-19-000992","line_url":"/filing/0000947871-19-000992","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71800.0,"shares_display":"71,800","price_per_share":19.59,"price_display":"19.59","price_state":"stated","total_value":1406562.0,"total_display":"1,406,562.00","total_whole":"1,406,562","shares_owned_after":8286838.0,"shares_owned_after_display":"8,286,838","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-24","filed_date":"2019-12-26","scope":"insider","n_lines":3},{"id":7859329,"accession":"0000947871-19-000992","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000947871-19-000992","line_url":"/filing/0000947871-19-000992","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":94285.0,"shares_display":"94,285","price_per_share":19.82,"price_display":"19.82","price_state":"stated","total_value":1868728.7,"total_display":"1,868,728.70","total_whole":"1,868,729","shares_owned_after":8335162.0,"shares_owned_after_display":"8,335,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2019-12-26","scope":"insider","n_lines":3},{"id":7859320,"accession":"0000947871-19-000992","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-19-000992","line_url":"/filing/0000947871-19-000992","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC; ORBIMED CAPITAL LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":342500.0,"shares_display":"342,500","price_per_share":19.66,"price_display":"19.66","price_state":"stated","total_value":6733550.0,"total_display":"6,733,550.00","total_whole":"6,733,550","shares_owned_after":8398697.0,"shares_owned_after_display":"8,398,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-20","filed_date":"2019-12-26","scope":"insider","n_lines":3},{"id":7968340,"accession":"0000947871-19-000977","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-19-000977","line_url":"/filing/0000947871-19-000977","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Alector, Inc.","issuer_ticker":"ALEC","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"ORBIMED CAPITAL LLC; ORBIMED ADVISORS LLC; OrbiMed Capital GP IV LLC","owner_display_name":"ORBIMED CAPITAL LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":954100.0,"shares_display":"954,100","price_per_share":18.52,"price_display":"18.52","price_state":"stated","total_value":17669932.0,"total_display":"17,669,932.00","total_whole":"17,669,932","shares_owned_after":8629418.0,"shares_owned_after_display":"8,629,418","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-19","scope":"insider","n_lines":3},{"id":8449845,"accession":"0001192482-19-000419","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001192482-19-000419","line_url":"/filing/0001192482-19-000419#line-1","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"TELA Bio, Inc.","issuer_ticker":"TELA","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP IV LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP IV LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":384615.0,"shares_display":"384,615","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":1568627.0,"shares_owned_after_display":"1,568,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-13","scope":"insider"}],"collapsed":true,"next_cursor":"2019-11-08|8449845","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001561921","name":"TELA Bio, Inc.","url":"/issuer/0001561921","role":"Ten percent owner","n_filings":3,"first_seen":"2019-11-13","last_seen":"2024-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001522860","name":"Acutus Medical, Inc.","url":"/issuer/0001522860","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2020-08-12","last_seen":"2021-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001653087","name":"Alector, Inc.","url":"/issuer/0001653087","role":"Director, Ten percent owner","n_filings":10,"first_seen":"2019-02-11","last_seen":"2020-04-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001510487","name":"Principia Biopharma Inc.","url":"/issuer/0001510487","role":"Ten percent owner","n_filings":2,"first_seen":"2018-09-20","last_seen":"2019-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001628738","name":"Audentes Therapeutics, Inc.","url":"/issuer/0001628738","role":"Ten percent owner","n_filings":4,"first_seen":"2017-09-11","last_seen":"2018-03-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001416792","name":"Relypsa Inc","url":"/issuer/0001416792","role":"Ten percent owner","n_filings":7,"first_seen":"2013-11-20","last_seen":"2016-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001493566","name":"Otonomy, Inc.","url":"/issuer/0001493566","role":"Director, Ten percent owner","n_filings":4,"first_seen":"2014-08-19","last_seen":"2015-11-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001270073","name":"INTERCEPT PHARMACEUTICALS INC","url":"/issuer/0001270073","role":"Director, Ten percent owner","n_filings":8,"first_seen":"2012-10-16","last_seen":"2015-03-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001576263","name":"Mirati Therapeutics, Inc.","url":"/issuer/0001576263","role":"Ten percent owner","n_filings":3,"first_seen":"2013-10-31","last_seen":"2015-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Director, Ten percent owner","n_filings":12,"first_seen":"2010-10-04","last_seen":"2013-02-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001502240","retrieved_at":"2026-08-23T12:55:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}